M&A / Growth Strategy

Acquisitions, de novos, integration, EBITDA, and enterprise value creation.

M&A / Growth Strategy guide

Healthcare M&A coverage on this site is organized around the decisions owners and operators face: whether and how to sell or partner, what moves value, how platforms and add-ons differ, and which regulators now expect notice before a deal closes. Start with the question closest to yours. Each pick is an HGS summary of a published source, with the source linked and dated. The full archive, newest first, follows below.

Preparing for a sale or a partner

Before talking to buyers, compare the paths: a full sale, a partnership or joint venture, or staying independent and growing through tuck-ins.

What drives valuation

Pricing conversations often turn on earnings quality, revenue cycle performance and how standardized operations are. Read deal-market data as context, not as a quote for your practice.

Platform or add-on: where consolidation is happening

Platforms set the operating model and add-ons plug into it. Track who is buying and where they are building to see where a practice might fit.

Regulatory review and notice laws

State notice laws and federal attention to MSO and antitrust questions are adding review steps to some deals, as the posts below describe. Build that time into the timeline.

Tool: Practice Valuation Calculator: a directional enterprise-value range from adjusted EBITDA and the drivers buyers weigh. Educational, not an appraisal.

Picks reviewed October 2026.

All posts, newest first